doi: 10.1113/jphysiol.2005.098558 82 TanigawaYLiJJustesenJMHornHAguirreMDeBoeverCet al
These data suggest that a mGIPR-Ab/GLP-1 peptideantibody conjugate may act on a different population of cells or via distinct molecular mechanism(s) compared to GIPR agonists like tirzepatide
While Mounjaro was initially approved for diabetes, the active ingredient (Tirzepatide) is widely prescribed off-label for weight management in patients without diabetes
Buckley AJ, Tan GD, Gruszka-Goh M, Scanlon PH, Ansari I, Suliman SGI
Possible Side Effects and Contraindications B12 injections are generally safe, even in high doses
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial